Organism name | Psidium guajava |
---|---|
Genus | Psidium |
Family | Myrtaceae |
Kingdom | Plantae |
Linked NCBI taxonomy name | Psidium guajava |
---|---|
Linked NCBI taxonomy ID | 120290 |
Linked level | species |
Family in NCBI taxonomy | Myrtaceae |
---|---|
ID | 3931 |
Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae |
---|---|
ID | 33090 |
Plant class | rosids |
---|---|
ID | 71275 |
Species | Activity |
---|---|
Psidium guajava L. | Abortifacient |
Psidium guajava L. | Amebicide |
Psidium guajava L. | Analgesic |
Psidium guajava L. | Anti-HIV |
Psidium guajava L. | Antiadhesive |
Psidium guajava L. | Antibacterial |
Psidium guajava L. | Anticolitic |
Psidium guajava L. | Anticonvulsant |
Psidium guajava L. | Antidiarrheal |
Psidium guajava L. | Antidiarrheic |
Psidium guajava L. | Antiemetic |
Psidium guajava L. | Antiepileptic |
Psidium guajava L. | Antigastritic |
Psidium guajava L. | AntiHIV |
Psidium guajava L. | Antihyperglycemic |
Psidium guajava L. | Antiinflammatory |
Psidium guajava L. | Antiinsomniac |
Psidium guajava L. | Antiischemic |
Psidium guajava L. | Antileukemic |
Psidium guajava L. | Antimalarial |
Psidium guajava L. | Antimutagenic |
Psidium guajava L. | Antimutagenic |
Psidium guajava L. | Antioxidant |
Psidium guajava L. | Antioxidant |
Psidium guajava L. | Antiperistaltic |
Psidium guajava L. | Antiplasmodial |
Psidium guajava L. | Antiproliferant |
Psidium guajava L. | Antiradicular |
Psidium guajava L. | Antiseptic |
Psidium guajava L. | Antiseptic |
Psidium guajava L. | Antispasmodic |
Psidium guajava L. | Antispasmodic |
Psidium guajava L. | Antitumor |
Psidium guajava L. | Antitumor |
Psidium guajava L. | Antitussive |
Psidium guajava L. | Antiviral |
Psidium guajava L. | Aperient |
Psidium guajava L. | Aphrodisiac |
Psidium guajava L. | Astringent |
Psidium guajava L. | Astringent |
Psidium guajava L. | Bactericide |
Psidium guajava L. | Candidicide |
Psidium guajava L. | Candidicide |
Psidium guajava L. | Cardiodepressant |
Psidium guajava L. | Cardioprotective |
Psidium guajava L. | Chemopreventive |
Psidium guajava L. | CNS-Depressant |
Psidium guajava L. | Digestive |
Psidium guajava L. | Emmenagogue |
Psidium guajava L. | Expectorant |
Psidium guajava L. | Expectorant |
Psidium guajava L. | Febrifuge |
Psidium guajava L. | Gastrotonic |
Psidium guajava L. | Hemostat |
Psidium guajava L. | Hemostat |
Psidium guajava L. | Hypoglycemic |
Psidium guajava L. | Hypoglycemic |
Psidium guajava L. | Hypotensive |
Psidium guajava L. | Myorelaxant |
Psidium guajava L. | Proaggregant |
Psidium guajava L. | Radioprotective |
Psidium guajava L. | Radioprotective |
Psidium guajava L. | Sedative |
Psidium guajava L. | Sedative |
Psidium guajava L. | Tonic |
Psidium guajava L. | Vasoconstrictor |
Psidium guajava L. | Vasoconstrictor |
Psidium guajava L. | Vulnerary |
KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
phytochemical
cluster |
figure |
---|---|---|---|---|---|---|---|---|
C00013836
![]() |
Quercetin 4'-glucuronide
/ 2-Hydroxy-4-(3,5,7-trihydroxy-4-oxo-4H-1-benzopyran-2-yl)phenyl beta-D-glucopyranosiduronic acid |
No. 2 | No. 15 |
![]() |
||||
C00005367
![]() |
Avicularin
/ Avicularine / Avicularoside / Quercetin 3-alpha-L-arabinofuranoside / Quercetin 3-O-alpha-L-arabinofuranoside |
CHEMBL471282
CHEMBL1590676 |
C041388
|
10 / 2 / 3 | No. 2 | No. 15 |
![]() |
|
C00005368
![]() |
Guaijaverin
/ Quercetin 3-O-alpha-L-arabinopyranoside |
CHEMBL183031
CHEMBL185461 CHEMBL488198 CHEMBL464507 CHEMBL520637 |
C088178
|
No. 2 | No. 15 |
![]() |
||
C00036480
![]() |
Colosic acid
/ 2alpha-Hydroxyursolic acid |
CHEMBL391533
CHEMBL237535 CHEMBL391534 CHEMBL574993 |
C113861
|
17 / 7 / 6 | No. 13 | No. 51 |
![]() |
|
C00003739
![]() |
Asiatic acid
|
CHEMBL278622
CHEMBL404313 CHEMBL1395292 CHEMBL1488520 CHEMBL1564373 CHEMBL1773214 |
C017032
|
11 / 14 / 43 | 1 / 0 | No. 13 | No. 51 |
![]() |
C00009117
![]() |
Prodelphinidin B1
/ Epigallocatechin-(4beta->8)-gallocatechin |
CHEMBL349509
CHEMBL161013 |
No. 16 | No. 19 |
![]() |
|||
C00037295
![]() |
Ilelatifol D
|
No. 23 | No. 51 |
![]() |
||||
C00000920
![]() |
beta-Cryptoxanthin
|
C010564
|
No. 26 | No. 59 |
![]() |
|||
C00000919
![]() |
beta-Carotene
|
CHEMBL1293
CHEMBL1966639 |
D019207
|
7 / 12 / 11 | 104 / 19 | No. 26 | No. 59 |
![]() |
C00023249
![]() |
(13Z)-beta,beta-Carotene
|
CHEMBL1293
CHEMBL1966639 |
7 / 12 / 11 | No. 26 | No. 59 |
![]() |
||
C00023248
![]() |
(9Z)-beta,beta-Carotene
|
CHEMBL1293
CHEMBL1966639 |
7 / 12 / 11 | No. 26 | No. 59 |
![]() |
||
C00023250
![]() |
(15Z)-beta,beta-Carotene
|
CHEMBL1293
CHEMBL1966639 |
7 / 12 / 11 | No. 26 | No. 59 |
![]() |
||
C00003776
![]() |
Lutein
/ (all-E)-Lutein / all-trans-(+)-Xanthophyll / (3R,3'R,6'R)-beta,epsilon-Carotene-3,3'-diol |
CHEMBL173929
CHEMBL172477 CHEMBL1559643 CHEMBL1979448 |
D014975
|
4 / 2 / 3 | 7 / 2 | No. 26 | No. 59 |
![]() |
C00037357
![]() |
Jacoumaric acid
|
CHEMBL507062
CHEMBL443637 |
No. 78 |
![]() |
||||
C00037334
![]() |
Isoneriucoumaric acid
|
No. 78 |
![]() |
|||||
C00037223
![]() |
Guavacoumaric acid
|
No. 78 |
![]() |
|||||
C00023251
![]() |
(9Z)-Lycopene
|
CHEMBL501174
CHEMBL1984187 |
6 / 13 / 13 | No. 97 | No. 59 |
![]() |
||
C00023253
![]() |
(15Z)-Lycopene
|
CHEMBL501174
CHEMBL1984187 |
6 / 13 / 13 | No. 97 | No. 59 |
![]() |
||
C00000913
![]() |
Phytofluene
|
No. 97 | No. 59 |
![]() |
||||
C00023252
![]() |
(13Z)-Lycopene
|
CHEMBL501174
CHEMBL1984187 |
6 / 13 / 13 | No. 97 | No. 59 |
![]() |
||
C00000911
![]() |
Lycopene
/ all-trans-Lycopene |
CHEMBL501174
CHEMBL1984187 |
C015329
|
6 / 13 / 13 | 84 / 13 | No. 97 | No. 59 |
![]() |
C00003785
![]() |
Rubixanthin
|
No. 131 | No. 59 |
![]() |
||||
C00000926
![]() |
gamma-Carotene
|
No. 131 | No. 59 |
![]() |
||||
C00009339
![]() |
Eugenigrandin A
|
CHEMBL508771
|
No. 142 |
![]() |
||||
C00009366
![]() |
Guavin D
|
No. 142 |
![]() |
|||||
C00009338
![]() |
Guajavin B
|
CHEMBL507287
|
No. 142 |
![]() |
||||
C00009365
![]() |
Guavin C
|
No. 142 |
![]() |
|||||
C00009364
![]() |
Guavin A
|
No. 142 |
![]() |
|||||
C00009337
![]() |
Psiguavin
|
No. 142 |
![]() |
|||||
C00009336
![]() |
Psidinin C
|
No. 142 |
![]() |
|||||
C00009335
![]() |
Psidinin B
|
No. 142 |
![]() |
|||||
C00009340
![]() |
Guajavin A
|
No. 142 |
![]() |
|||||
C00009334
![]() |
Psidinin A
|
No. 142 |
![]() |
|||||
C00037224
![]() |
Guavanoic acid
|
No. 177 |
![]() |
|||||
C00002909
![]() |
Casuarictin
|
CHEMBL305099
CHEMBL446979 |
C073064
|
No. 226 | No. 81 |
![]() |
||
C00002910
![]() |
Casuarinin
|
CHEMBL79244
CHEMBL507387 |
11 / 2 / 2 | No. 226 | No. 81 |
![]() |
||
C00002938
![]() |
Tellimagrandin I
|
CHEMBL450376
|
C087926
|
7 / 0 | No. 302 | No. 81 |
![]() |
|
C00019308
![]() |
Doursterol
/ Daucosterin / 3-O-beta-D-Glucopyranosyl sitosterol / beta-Sitosterol 3-O-beta-D-glucopyranoside |
CHEMBL197711
CHEMBL506678 CHEMBL2304043 |
C011015
|
5 / 4 / 2 | 0 / 3 | No. 520 |
![]() |
|
C00022949
![]() |
(3S,5R,8S)-5,8-Epoxy-5,8-dihydro-beta,beta-caroten-3-ol
|
No. 664 | No. 59 |
![]() |
||||
C00023254
![]() |
(8'R)-Neochrome
|
No. 664 | No. 59 |
![]() |
||||
C00002647
![]() |
Gallic acid
|
CHEMBL288114
|
D005707
|
42 / 53 / 68 | 52 / 16 | No. 817 | No. 81 |
![]() |
accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|
O75496 | Geminin | Unclassified protein | C00000911 C00000919 C00003776 C00005367 C00023248 C00023249 C00023250 C00023251 C00023252 C00023253 C00036480 | 0 / 0 |
P02545 | Prelamin-A/C | Unclassified protein | C00000911 C00000919 C00002647 C00023248 C00023249 C00023250 C00023251 C00023252 C00023253 | 11 / 10 |
Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | Enzyme | C00000911 C00002647 C00003776 C00023251 C00023252 C00023253 | 0 / 0 |
P11473 | Vitamin D3 receptor | NR1I1 | C00000911 C00002647 C00003776 C00023251 C00023252 C00023253 | 2 / 3 |
Q9UBT6 | DNA polymerase kappa | Enzyme | C00000911 C00002647 C00005367 C00023251 C00023252 C00023253 | 0 / 0 |
O94782 | Ubiquitin carboxyl-terminal hydrolase 1 | Enzyme | C00000911 C00003776 C00023251 C00023252 C00023253 | 0 / 0 |
P00352 | Retinal dehydrogenase 1 | Enzyme | C00000919 C00002647 C00023248 C00023249 C00023250 | 0 / 0 |
Q92830 | Histone acetyltransferase KAT2A | Enzyme | C00000919 C00002647 C00023248 C00023249 C00023250 | 0 / 0 |
P07550 | Beta-2 adrenergic receptor | Adrenergic receptor | C00000919 C00023248 C00023249 C00023250 | 0 / 1 |
P08588 | Beta-1 adrenergic receptor | Adrenergic receptor | C00000919 C00023248 C00023249 C00023250 | 1 / 0 |
P13945 | Beta-3 adrenergic receptor | Adrenergic receptor | C00000919 C00023248 C00023249 C00023250 | 0 / 0 |
P18031 | Tyrosine-protein phosphatase non-receptor type 1 | Tyr | C00003739 C00019308 C00036480 | 0 / 0 |
P15121 | Aldose reductase | Enzyme | C00002647 C00003739 C00005367 | 0 / 0 |
Q16236 | Nuclear factor erythroid 2-related factor 2 | Unclassified protein | C00002647 C00036480 | 0 / 0 |
P27695 | DNA-(apurinic or apyrimidinic site) lyase | Enzyme | C00002647 C00003739 | 0 / 0 |
P10636 | Microtubule-associated protein tau | Unclassified protein | C00002647 C00003739 | 4 / 3 |
Q96QE3 | ATPase family AAA domain-containing protein 5 | Unclassified protein | C00005367 C00036480 | 0 / 0 |
P17706 | Tyrosine-protein phosphatase non-receptor type 2 | Tyr | C00003739 C00036480 | 0 / 1 |
P06746 | DNA polymerase beta | Enzyme | C00019308 C00036480 | 0 / 0 |
P04637 | Cellular tumor antigen p53 | Transcription Factor | C00002647 C00003739 | 7 / 37 |
O94925 | Glutaminase kidney isoform, mitochondrial | Enzyme | C00002647 C00005367 | 0 / 0 |
P22748 | Carbonic anhydrase 4 | Lyase | C00002647 | 1 / 1 |
Q9ULX7 | Carbonic anhydrase 14 | Lyase | C00002647 | 0 / 0 |
P10586 | Receptor-type tyrosine-protein phosphatase F | Receptor tyrosine-protein phosphatase | C00036480 | 0 / 0 |
P28845 | Corticosteroid 11-beta-dehydrogenase isozyme 1 | Enzyme | C00036480 | 1 / 1 |
P16581 | E-selectin | Adhesion | C00002647 | 0 / 0 |
O43570 | Carbonic anhydrase 12 | Lyase | C00002647 | 1 / 2 |
P39748 | Flap endonuclease 1 | Enzyme | C00005367 | 0 / 0 |
P78536 | Disintegrin and metalloproteinase domain-containing protein 17 | M12B | C00002647 | 1 / 0 |
P42858 | Huntingtin | Unclassified protein | C00036480 | 1 / 1 |
P84022 | Mothers against decapentaplegic homolog 3 | Unclassified protein | C00036480 | 2 / 0 |
P00918 | Carbonic anhydrase 2 | Lyase | C00002647 | 1 / 2 |
P16473 | Thyrotropin receptor | Glycohormone receptor | C00003739 | 3 / 2 |
P10145 | Interleukin-8 | Secreted protein | C00002647 | 0 / 0 |
P00915 | Carbonic anhydrase 1 | Lyase | C00002647 | 0 / 0 |
P49841 | Glycogen synthase kinase-3 beta | Gsk | C00019308 | 0 / 0 |
Q9Y253 | DNA polymerase eta | Enzyme | C00005367 | 1 / 1 |
Q9Y468 | Lethal(3)malignant brain tumor-like protein 1 | Unclassified protein | C00005367 | 0 / 0 |
P11308 | Transcriptional regulator ERG | Unclassified protein | C00005367 | 1 / 2 |
P83916 | Chromobox protein homolog 1 | Unclassified protein | C00036480 | 0 / 0 |
P08047 | Transcription factor Sp1 | Unclassified protein | C00019308 | 0 / 0 |
P00734 | Prothrombin | S1A | C00019308 | 4 / 2 |
P04150 | Glucocorticoid receptor | NR3C1 | C00002647 | 0 / 1 |
Q96RI1 | Bile acid receptor | NR1H4 | C00003739 | 0 / 0 |
P18433 | Receptor-type tyrosine-protein phosphatase alpha | Receptor tyrosine-protein phosphatase | C00036480 | 0 / 0 |
P08581 | Hepatocyte growth factor receptor | TK tyrosine-protein kinase MET subfamily | C00002647 | 2 / 3 |
P28482 | Mitogen-activated protein kinase 1 | Erk | C00002647 | 0 / 0 |
Q16790 | Carbonic anhydrase 9 | Lyase | C00002647 | 0 / 1 |
Q99714 | 3-hydroxyacyl-CoA dehydrogenase type-2 | Enzyme | C00002647 | 3 / 3 |
P15428 | 15-hydroxyprostaglandin dehydrogenase [NAD(+)] | Enzyme | C00002647 | 2 / 2 |
Q8TDU6 | G-protein coupled bile acid receptor 1 | Steroid-like ligand receptor | C00003739 | 0 / 0 |
P03372 | Estrogen receptor | NR3A1 | C00002647 | 1 / 1 |
P12821 | Angiotensin-converting enzyme | M2 | C00002647 | 4 / 2 |
P14151 | L-selectin | Adhesion | C00002647 | 0 / 0 |
P16109 | P-selectin | Adhesion | C00002647 | 1 / 0 |
P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00003739 | 0 / 1 |
Q9UNA4 | DNA polymerase iota | Enzyme | C00005367 | 0 / 0 |
P04406 | Glyceraldehyde-3-phosphate dehydrogenase | Enzyme | C00002647 | 0 / 0 |
P22309 | UDP-glucuronosyltransferase 1-1 | Enzyme | C00002647 | 5 / 1 |
P43166 | Carbonic anhydrase 7 | Lyase | C00002647 | 0 / 0 |
P35218 | Carbonic anhydrase 5A, mitochondrial | Lyase | C00002647 | 0 / 0 |
P07451 | Carbonic anhydrase 3 | Lyase | C00002647 | 0 / 0 |
Q9Y2D0 | Carbonic anhydrase 5B, mitochondrial | Lyase | C00002647 | 0 / 0 |
P29350 | Tyrosine-protein phosphatase non-receptor type 6 | Tyr | C00036480 | 0 / 0 |
P23280 | Carbonic anhydrase 6 | Lyase | C00002647 | 0 / 0 |
P80365 | Corticosteroid 11-beta-dehydrogenase isozyme 2 | Enzyme | C00036480 | 1 / 1 |
P23469 | Receptor-type tyrosine-protein phosphatase epsilon | Receptor tyrosine-protein phosphatase | C00036480 | 0 / 0 |
Q13093 | Platelet-activating factor acetylhydrolase | Enzyme | C00002647 | 3 / 0 |
B2RXH2 | Lysine-specific demethylase 4E | Enzyme | C00002647 | 0 / 0 |
P35354 | Prostaglandin G/H synthase 2 | Oxidoreductase | C00002647 | 0 / 3 |
Q9NUW8 | Tyrosyl-DNA phosphodiesterase 1 | Enzyme | C00002647 | 1 / 1 |
Q05513 | Protein kinase C zeta type | Iota | C00002910 | 0 / 0 |
Q04759 | Protein kinase C theta type | Delta | C00002910 | 0 / 1 |
Q02156 | Protein kinase C epsilon type | Eta | C00002910 | 0 / 0 |
O94806 | Serine/threonine-protein kinase D3 | Pkd | C00002910 | 0 / 0 |
P17252 | Protein kinase C alpha type | Alpha | C00002910 | 0 / 0 |
Q05655 | Protein kinase C delta type | Delta | C00002910 | 0 / 0 |
P05129 | Protein kinase C gamma type | Alpha | C00002910 | 1 / 1 |
P05771 | Protein kinase C beta type | Alpha | C00002910 | 0 / 0 |
P24723 | Protein kinase C eta type | Eta | C00002910 | 1 / 0 |
P41743 | Protein kinase C iota type | Iota | C00002910 | 0 / 0 |
Q15139 | Serine/threonine-protein kinase D1 | Pkd | C00002910 | 0 / 0 |
O60218 | Aldo-keto reductase family 1 member B10 | Enzyme | C00003739 | 0 / 0 |
Q99700 | Ataxin-2 | Unclassified protein | C00036480 | 1 / 1 |
Q16637 | Survival motor neuron protein | Unclassified protein | C00002647 | 4 / 1 |
P11217 | Glycogen phosphorylase, muscle form | Enzyme | C00036480 | 1 / 1 |
gene | gene name | gene description | KNApSAcK metabolite in interactions |
---|---|---|---|
581 | BAX, BCL2L4 | BCL2-associated X protein |
C00000919
C00002647
C00003776
|
5595 | MAPK3, ERK-1, ERK1, ERT2, HS44KDAP, HUMKER1A, P44ERK1, P44MAPK, PRKM3, p44-ERK1, p44-MAPK | mitogen-activated protein kinase 3 (EC:2.7.11.24) |
C00000911
C00000919
C00002647
|
7124 | TNF, DIF, TNF-alpha, TNFA, TNFSF2 | tumor necrosis factor |
C00000911
C00000919
C00002647
|
7157 | TP53, BCC7, LFS1, P53, TRP53 | tumor protein p53 |
C00000911
C00002647
|
5594 | MAPK1, ERK, ERK2, ERT1, MAPK2, P42MAPK, PRKM1, PRKM2, p38, p40, p41, p41mapk | mitogen-activated protein kinase 1 (EC:2.7.11.24) |
C00000919
C00002647
|
3576 | IL8, CXCL8, GCP-1, GCP1, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1 | interleukin 8 |
C00000919
C00002647
|
7852 | CXCR4, CD184, D2S201E, FB22, HM89, HSY3RR, LAP3, LCR1, LESTR, NPY3R, NPYR, NPYRL, NPYY3R, WHIM | chemokine (C-X-C motif) receptor 4 |
C00000919
C00002647
|
836 | CASP3, CPP32, CPP32B, SCA-1 | caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) |
C00000919
C00002647
|
841 | CASP8, ALPS2B, CAP4, Casp-8, FLICE, MACH, MCH5 | caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61) |
C00000911
C00002647
|
847 | CAT | catalase (EC:1.11.1.6) |
C00000911
C00003776
|
595 | CCND1, BCL1, D11S287E, PRAD1, U21B31 | cyclin D1 |
C00000911
C00003776
|
898 | CCNE1, CCNE | cyclin E1 |
C00000911
C00002647
|
596 | BCL2, Bcl-2, PPP1R50 | B-cell CLL/lymphoma 2 |
C00002647
C00003776
|
207 | AKT1, AKT, CWS6, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA | v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1) |
C00000911
C00002647
|
4255 | MGMT | O-6-methylguanine-DNA methyltransferase (EC:2.1.1.63) |
C00000919
C00002647
|
5743 | PTGS2, COX-2, COX2, GRIPGHS, PGG/HS, PGHS-2, PHS-2, hCox-2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) |
C00002647
C00003776
|
6195 | RPS6KA1, HU-1, MAPKAPK1A, RSK, RSK1 | ribosomal protein S6 kinase, 90kDa, polypeptide 1 (EC:2.7.11.1) |
C00000911
C00002647
|
1026 | CDKN1A, CAP20, CDKN1, CIP1, MDA-6, P21, SDI1, WAF1, p21CIP1 | cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
C00000911
C00002647
|
5591 | PRKDC, DNA-PKcs, DNAPK, DNPK1, HYRC, HYRC1, XRCC7, p350 | protein kinase, DNA-activated, catalytic polypeptide (EC:2.7.11.1) |
C00000911
C00002647
|
4842 | NOS1, IHPS1, N-NOS, NC-NOS, NOS, bNOS, nNOS | nitric oxide synthase 1 (neuronal) (EC:1.14.13.39) |
C00000911
C00000919
|
5599 | MAPK8, JNK, JNK-46, JNK1, JNK1A2, JNK21B1/2, PRKM8, SAPK1, SAPK1c | mitogen-activated protein kinase 8 (EC:2.7.11.24) |
C00000911
C00002647
|
1576 | CYP3A4, CP33, CP34, CYP3A, CYP3A3, CYPIIIA3, CYPIIIA4, HLP, NF-25, P450C3, P450PCN1 | cytochrome P450, family 3, subfamily A, polypeptide 4 (EC:1.14.13.67 1.14.13.97 1.14.13.32 1.14.13.157) |
C00000911
C00000919
|
5970 | RELA, NFKB3, p65 | v-rel avian reticuloendotheliosis viral oncogene homolog A |
C00002647
C00003776
|
5604 | MAP2K1, CFC3, MAPKK1, MEK1, MKK1, PRKMK1 | mitogen-activated protein kinase kinase 1 (EC:2.7.12.2) |
C00000911
C00002647
|
2099 | ESR1, ER, ESR, ESRA, ESTRR, Era, NR3A1 | estrogen receptor 1 |
C00000911
C00000919
|
2100 | ESR2, ER-BETA, ESR-BETA, ESRB, ESTRB, Erb, NR3A2 | estrogen receptor 2 (ER beta) |
C00000911
C00000919
|
3949 | LDLR, FH, FHC, LDLCQ2 | low density lipoprotein receptor |
C00000911
C00002647
|
3713 | IVL | involucrin |
C00000911
C00000919
|
356 | FASLG, ALPS1B, APT1LG1, APTL, CD178, CD95-L, CD95L, FASL, TNFSF6 | Fas ligand (TNF superfamily, member 6) |
C00000911
C00002647
|
4153 | MBL2, COLEC1, HSMBPC, MBL, MBL2D, MBP, MBP-C, MBP1, MBPD | mannose-binding lectin (protein C) 2, soluble |
C00000919
|
2701 | GJA4, CX37 | gap junction protein, alpha 4, 37kDa |
C00000911
|
2702 | GJA5, ATFB11, CX40 | gap junction protein, alpha 5, 40kDa |
C00000911
|
2879 | GPX4, GPx-4, GSHPx-4, MCSP, PHGPx, snGPx, snPHGPx | glutathione peroxidase 4 (EC:1.11.1.12) |
C00000911
|
3146 | HMGB1, HMG1, HMG3, SBP-1 | high mobility group box 1 |
C00000911
|
3383 | ICAM1, BB2, CD54, P3.58 | intercellular adhesion molecule 1 |
C00000911
|
3479 | IGF1, IGF-I, IGF1A, IGFI | insulin-like growth factor 1 (somatomedin C) |
C00000911
|
3480 | IGF1R, CD221, IGFIR, IGFR, JTK13 | insulin-like growth factor 1 receptor (EC:2.7.10.1) |
C00000911
|
3485 | IGFBP2, IBP2, IGF-BP53 | insulin-like growth factor binding protein 2, 36kDa |
C00000911
|
2188 | FANCF, FAF | Fanconi anemia, complementation group F |
C00000911
|
3716 | JAK1, JAK1A, JAK1B, JTK3 | Janus kinase 1 (EC:2.7.10.2) |
C00000911
|
3725 | JUN, AP-1, AP1, c-Jun | jun proto-oncogene |
C00000911
|
3796 | KIF2A, CDCBM3, HK2, KIF2 | kinesin heavy chain member 2A |
C00000911
|
3838 | KPNA2, IPOA1, QIP2, RCH1, SRP1alpha | karyopherin alpha 2 (RAG cohort 1, importin alpha 1) |
C00000911
|
2176 | FANCC, FA3, FAC, FACC | Fanconi anemia, complementation group C |
C00000911
|
3988 | LIPA, CESD, LAL | lipase A, lysosomal acid, cholesterol esterase (EC:3.1.1.13) |
C00000911
|
1981 | EIF4G1, EIF-4G1, EIF4F, EIF4G, EIF4GI, P220, PARK18 | eukaryotic translation initiation factor 4 gamma, 1 |
C00000911
|
5605 | MAP2K2, CFC4, MAPKK2, MEK2, MKK2, PRKMK2 | mitogen-activated protein kinase kinase 2 (EC:2.7.12.2) |
C00000911
|
6416 | MAP2K4, JNKK, JNKK1, MAPKK4, MEK4, MKK4, PRKMK4, SAPKK-1, SAPKK1, SEK1, SERK1, SKK1 | mitogen-activated protein kinase kinase 4 (EC:2.7.12.2) |
C00000911
|
5608 | MAP2K6, MAPKK6, MEK6, MKK6, PRKMK6, SAPKK-3, SAPKK3 | mitogen-activated protein kinase kinase 6 (EC:2.7.12.2) |
C00000911
|
1432 | MAPK14, CSBP, CSBP1, CSBP2, CSPB1, EXIP, Mxi2, PRKM14, PRKM15, RK, SAPK2A, p38, p38ALPHA | mitogen-activated protein kinase 14 (EC:2.7.11.24) |
C00000911
|
1643 | DDB2, DDBB, UV-DDB2 | damage-specific DNA binding protein 2, 48kDa |
C00000911
|
23418 | CRB1, LCA8, RP12 | crumbs homolog 1 (Drosophila) |
C00000911
|
4247 | MGAT2, CDG2A, CDGS2, GLCNACTII, GNT-II, GNT2 | mannosyl (alpha-1,6-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase (EC:2.4.1.143) |
C00000911
|
100507436 | MICA, MIC-A, PERB11.1 | MHC class I polypeptide-related sequence A |
C00000911
|
4292 | MLH1, COCA2, FCC2, HNPCC, HNPCC2, hMLH1 | mutL homolog 1 |
C00000911
|
4436 | MSH2, COCA1, FCC1, HNPCC, HNPCC1, LCFS2 | mutS homolog 2 |
C00000911
|
2956 | MSH6, GTBP, GTMBP, HNPCC5, HSAP, p160 | mutS homolog 6 |
C00000911
|
1114 | CHGB, SCG1 | chromogranin B (secretogranin 1) |
C00000911
|
8021 | NUP214, CAIN, CAN, D9S46E, N214, p250 | nucleoporin 214kDa |
C00000911
|
5320 | PLA2G2A, MOM1, PLA2, PLA2B, PLA2L, PLA2S, PLAS1, sPLA2 | phospholipase A2, group IIA (platelets, synovial fluid) (EC:3.1.1.4) |
C00000911
|
1113 | CHGA, CGA | chromogranin A (parathyroid secretory protein 1) |
C00000911
|
10111 | RAD50, NBSLD, RAD502, hRad50 | RAD50 homolog (S. cerevisiae) |
C00000911
|
8045 | RASSF7, C11orf13, HRAS1, HRC1 | Ras association (RalGDS/AF-6) domain family (N-terminal) member 7 |
C00000911
|
5925 | RB1, OSRC, RB, p105-Rb, pRb, pp110 | retinoblastoma 1 |
C00000911
|
5962 | RDX, DFNB24 | radixin |
C00000911
|
1025 | CDK9, C-2k, CDC2L4, CTK1, PITALRE, TAK | cyclin-dependent kinase 9 (EC:2.7.11.23 2.7.11.22) |
C00000911
|
6197 | RPS6KA3, CLS, HU-3, ISPK-1, MAPKAPK1B, MRX19, RSK, RSK2, S6K-alpha3, p90-RSK2, pp90RSK2 | ribosomal protein S6 kinase, 90kDa, polypeptide 3 (EC:2.7.11.1) |
C00000911
|
6241 | RRM2, R2, RR2, RR2M | ribonucleotide reductase M2 (EC:1.17.4.1) |
C00000911
|
6401 | SELE, CD62E, ELAM, ELAM1, ESEL, LECAM2 | selectin E |
C00000911
|
6414 | SEPP1, SELP, SeP | selenoprotein P, plasma, 1 |
C00000911
|
4088 | SMAD3, HSPC193, HsT17436, JV15-2, LDS1C, LDS3, MADH3 | SMAD family member 3 |
C00000911
|
8243 | SMC1A, CDLS2, DXS423E, SB1.8, SMC1, SMC1L1, SMC1alpha, SMCB | structural maintenance of chromosomes 1A |
C00000911
|
6774 | STAT3, APRF, HIES | signal transducer and activator of transcription 3 (acute-phase response factor) |
C00000911
|
7031 | TFF1, BCEI, D21S21, HP1.A, HPS2, pNR-2, pS2 | trefoil factor 1 |
C00000911
|
7980 | TFPI2, PP5, REF1, TFPI-2 | tissue factor pathway inhibitor 2 |
C00000911
|
7039 | TGFA, TFGA | transforming growth factor, alpha |
C00000911
|
7097 | TLR2, CD282, TIL4 | toll-like receptor 2 |
C00000911
|
7099 | TLR4, ARMD10, CD284, TLR-4, TOLL | toll-like receptor 4 |
C00000911
|
1022 | CDK7, CAK1, CDKN7, HCAK, MO15, STK1, p39MO15 | cyclin-dependent kinase 7 (EC:2.7.11.23 2.7.11.22) |
C00000911
|
1020 | CDK5, PSSALRE | cyclin-dependent kinase 5 (EC:2.7.11.22) |
C00000911
|
7412 | VCAM1, CD106, INCAM-100 | vascular cell adhesion molecule 1 |
C00000911
|
7415 | VCP, ALS14, IBMPFD, IBMPFD1, TERA, p97 | valosin containing protein (EC:3.6.4.6) |
C00000911
|
7485 | WRB, CHD5 | tryptophan rich basic protein |
C00000911
|
7697 | ZNF138, pHZ-32 | zinc finger protein 138 |
C00000911
|
7416 | VDAC1, PORIN, VDAC-1 | voltage-dependent anion channel 1 |
C00003739
|
43 | ACHE, ACEE, ARACHE, N-ACHE, YT | acetylcholinesterase (EC:3.1.1.7) |
C00002938
|
2623 | GATA1, ERYF1, GATA-1, GF-1, GF1, NF-E1, NFE1, XLANP, XLTDA, XLTT | GATA binding protein 1 (globin transcription factor 1) |
C00002938
|
2624 | GATA2, DCML, MONOMAC, NFE1B | GATA binding protein 2 |
C00002938
|
2993 | GYPA, CD235a, GPA, GPErik, GPSAT, HGpMiV, HGpMiXI, HGpSta(C), MN, MNS, PAS-2 | glycophorin A (MNS blood group) |
C00002938
|
3145 | HMBS, PBG-D, PBGD, PORC, UPS | hydroxymethylbilane synthase (EC:2.5.1.61) |
C00002938
|
3690 | ITGB3, BDPLT16, BDPLT2, CD61, GP3A, GPIIIa, GT | integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) |
C00002938
|
4778 | NFE2, NF-E2, p45 | nuclear factor, erythroid 2 |
C00002938
|
5243 | ABCB1, ABC20, CD243, CLCS, GP170, MDR1, P-GP, PGY1 | ATP-binding cassette, sub-family B (MDR/TAP), member 1 (EC:3.6.3.44) |
C00002647
|
25 | ABL1, ABL, JTK7, bcr/abl, c-ABL, p150, v-abl | c-abl oncogene 1, non-receptor tyrosine kinase (EC:2.7.10.2) |
C00002647
|
338 | APOB, FLDB, LDLCQ4 | apolipoprotein B |
C00002647
|
472 | ATM, AT1, ATA, ATC, ATD, ATDC, ATE, TEL1, TELO1 | ataxia telangiectasia mutated (EC:2.7.11.1) |
C00002647
|
545 | ATR, FCTCS, FRP1, MEC1, SCKL, SCKL1 | ataxia telangiectasia and Rad3 related (EC:2.7.11.1) |
C00002647
|
1019 | CDK4, CMM3, PSK-J3 | cyclin-dependent kinase 4 (EC:2.7.11.22) |
C00000911
|
983 | CDK1, CDC2, CDC28A, P34CDC2 | cyclin-dependent kinase 1 (EC:2.7.11.23 2.7.11.22) |
C00000911
|
613 | BCR, ALL, BCR1, CML, D22S11, D22S662, PHL | breakpoint cluster region (EC:2.7.11.1) |
C00002647
|
673 | BRAF, B-RAF1, BRAF1, NS7, RAFB1 | v-raf murine sarcoma viral oncogene homolog B (EC:2.7.11.1) |
C00000911
|
998 | CDC42, CDC42Hs, G25K | cell division cycle 42 |
C00002647
|
1027 | CDKN1B, CDKN4, KIP1, MEN1B, MEN4, P27KIP1 | cyclin-dependent kinase inhibitor 1B (p27, Kip1) |
C00002647
|
1147 | CHUK, IKBKA, IKK-alpha, IKK1, IKKA, NFKBIKA, TCF16 | conserved helix-loop-helix ubiquitous kinase (EC:2.7.11.10) |
C00002647
|
8314 | BAP1, HUCEP-13, UCHL2 | BRCA1 associated protein-1 (ubiquitin carboxy-terminal hydrolase) (EC:3.4.19.12) |
C00000911
|
54205 | CYCS, CYC, HCS, THC4 | cytochrome c, somatic |
C00002647
|
2551 | GABPA, E4TF1-60, E4TF1A, NFT2, NRF2, NRF2A, RCH04A07 | GA binding protein transcription factor, alpha subunit 60kDa |
C00002647
|
2885 | GRB2, ASH, EGFRBP-GRB2, Grb3-3, MST084, MSTP084, NCKAP2 | growth factor receptor-bound protein 2 |
C00002647
|
3551 | IKBKB, IKK-beta, IKK2, IKKB, NFKBIKB | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta (EC:2.7.11.10) |
C00002647
|
3569 | IL6, BSF2, HGF, HSF, IFNB2, IL-6 | interleukin 6 (interferon, beta 2) |
C00002647
|
571 | BACH1, BACH-1 | BTB and CNC homology 1, basic leucine zipper transcription factor 1 |
C00000911
|
367 | AR, AIS, DHTR, HUMARA, HYSP1, KD, NR3C4, SBMA, SMAX1, TFM | androgen receptor |
C00000911
|
5601 | MAPK9, JNK-55, JNK2, JNK2A, JNK2ALPHA, JNK2B, JNK2BETA, PRKM9, SAPK, SAPK1a, p54a, p54aSAPK | mitogen-activated protein kinase 9 (EC:2.7.11.24) |
C00002647
|
118 | ADD1, ADDA | adducin 1 (alpha) |
C00000911
|
4313 | MMP2, CLG4, CLG4A, MMP-II, MONA, TBE-1 | matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) (EC:3.4.24.24) |
C00002647
|
4316 | MMP7, MMP-7, MPSL1, PUMP-1 | matrix metallopeptidase 7 (matrilysin, uterine) (EC:3.4.24.23) |
C00002647
|
4318 | MMP9, CLG4B, GELB, MANDP2, MMP-9 | matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) |
C00002647
|
4793 | NFKBIB, IKBB, TRIP9 | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, beta |
C00002647
|
5578 | PRKCA, AAG6, PKC-alpha, PKCA, PRKACA | protein kinase C, alpha (EC:2.7.11.13) |
C00002647
|
196 | AHR, bHLHe76 | aryl hydrocarbon receptor |
C00000911
|
5879 | RAC1, Rac-1, TC-25, p21-Rac1 | ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) |
C00002647
|
19412 |
C00002647
|
||
177 | AGER, RAGE | advanced glycosylation end product-specific receptor |
C00000911
|
387 | RHOA, ARH12, ARHA, RHO12, RHOH12 | ras homolog family member A |
C00002647
|
388 | RHOB, ARH6, ARHB, MST081, MSTP081, RHOH6 | ras homolog family member B |
C00002647
|
9252 | RPS6KA5, MSK1, MSPK1, RLPK | ribosomal protein S6 kinase, 90kDa, polypeptide 5 (EC:2.7.11.1) |
C00002647
|
6622 | SNCA, NACP, PARK1, PARK4, PD1 | synuclein, alpha (non A4 component of amyloid precursor) |
C00002647
|
6817 | SULT1A1, HAST1/HAST2, P-PST, PST, ST1A1, ST1A3, STP, STP1, TSPST1 | sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1 (EC:2.8.2.1) |
C00002647
|
7224 | TRPC5, TRP5 | transient receptor potential cation channel, subfamily C, member 5 |
C00002647
|
7422 | VEGFA, MVCD1, VEGF, VPF | vascular endothelial growth factor A |
C00002647
|
331 | XIAP, API3, BIRC4, IAP-3, ILP1, MIHA, XLP2, hIAP-3, hIAP3 | X-linked inhibitor of apoptosis |
C00002647
|
598 | BCL2L1, BCL-XL/S, BCL2L, BCLX, BCLXL, BCLXS, Bcl-X, PPP1R52, bcl-xL, bcl-xS | BCL2-like 1 |
C00003776
|
124 | ADH1A, ADH1 | alcohol dehydrogenase 1A (class I), alpha polypeptide (EC:1.1.1.1) |
C00000919
|
128 | ADH5, ADH-3, ADHX, FALDH, FDH, GSH-FDH, GSNOR | alcohol dehydrogenase 5 (class III), chi polypeptide (EC:1.1.1.1 1.1.1.284) |
C00000919
|
221 | ALDH3B1, ALDH4, ALDH7 | aldehyde dehydrogenase 3 family, member B1 (EC:1.2.1.5) |
C00000919
|
8659 | ALDH4A1, ALDH4, P5CD, P5CDh | aldehyde dehydrogenase 4 family, member A1 (EC:1.2.1.88) |
C00000919
|
287 | ANK2, ANK-2, LQT4, brank-2 | ankyrin 2, neuronal |
C00000919
|
288 | ANK3, ANKYRIN-G, MRT37 | ankyrin 3, node of Ranvier (ankyrin G) |
C00000919
|
427 | ASAH1, AC, ACDase, ASAH, PHP, PHP32, SMAPME | N-acylsphingosine amidohydrolase (acid ceramidase) 1 (EC:3.5.1.23) |
C00000919
|
51665 | ASB1, ASB-1 | ankyrin repeat and SOCS box containing 1 |
C00000919
|
140462 | ASB9 | ankyrin repeat and SOCS box containing 9 |
C00000919
|
9531 | BAG3, BAG-3, BIS, CAIR-1, MFM6 | BCL2-associated athanogene 3 |
C00000919
|
9530 | BAG4, BAG-4, SODD | BCL2-associated athanogene 4 |
C00000919
|
9529 | BAG5, BAG-5 | BCL2-associated athanogene 5 |
C00000919
|
53630 | BCMO1, BCDO, BCDO1, BCMO, BCO, BCO1 | beta-carotene 15,15'-monooxygenase 1 (EC:1.14.99.36) |
C00000919
|
999 | CDH1, Arc-1, CD324, CDHE, ECAD, LCAM, UVO | cadherin 1, type 1, E-cadherin (epithelial) |
C00000919
|
8837 | CFLAR, CASH, CASP8AP1, CLARP, Casper, FLAME, FLAME-1, FLAME1, FLIP, I-FLICE, MRIT, c-FLIP, c-FLIPL, c-FLIPR, c-FLIPS | CASP8 and FADD-like apoptosis regulator |
C00000919
|
9071 | CLDN10, CPETRL3, OSP-L | claudin 10 |
C00000919
|
51208 | CLDN18, SFTA5, SFTPJ | claudin 18 |
C00000919
|
1277 | COL1A1, OI4 | collagen, type I, alpha 1 |
C00000919
|
1282 | COL4A1, HANAC, ICH, POREN1, arresten | collagen, type IV, alpha 1 |
C00000919
|
1284 | COL4A2, ICH, POREN2 | collagen, type IV, alpha 2 |
C00000919
|
8738 | CRADD, MRT34, RAIDD | CASP2 and RIPK1 domain containing adaptor with death domain |
C00000919
|
1508 | CTSB, APPS, CPSB | cathepsin B (EC:3.4.22.1) |
C00000919
|
6387 | CXCL12, IRH, PBSF, SCYB12, SDF1, TLSF, TPAR1, SDF1A, SDF1B | chemokine (C-X-C motif) ligand 12 |
C00000919
|
6372 | CXCL6, CKA-3, GCP-2, GCP2, SCYB6 | chemokine (C-X-C motif) ligand 6 |
C00000919
|
4283 | CXCL9, CMK, Humig, MIG, SCYB9, crg-10 | chemokine (C-X-C motif) ligand 9 |
C00000919
|
1592 | CYP26A1, CP26, CYP26, P450RAI, P450RAI1 | cytochrome P450, family 26, subfamily A, polypeptide 1 (EC:1.14.-.-) |
C00000919
|
1559 | CYP2C9, CPC9, CYP2C, CYP2C10, CYPIIC9, P450IIC9 | cytochrome P450, family 2, subfamily C, polypeptide 9 (EC:1.14.13.48 1.14.13.49 1.14.13.80) |
C00000919
|
64816 | CYP3A43 | cytochrome P450, family 3, subfamily A, polypeptide 43 (EC:1.14.14.1) |
C00000919
|
1746 | DLX2, TES-1, TES1 | distal-less homeobox 2 |
C00000919
|
1748 | DLX4, BP1, DLX7, DLX8, DLX9 | distal-less homeobox 4 |
C00000919
|
2068 | ERCC2, COFS2, EM9, TTD, XPD | excision repair cross-complementing rodent repair deficiency, complementation group 2 (EC:3.6.4.12) |
C00000919
|
23017 | FAIM2, LFG, LFG2, NGP35, NMP35, TMBIM2 | Fas apoptotic inhibitory molecule 2 |
C00000919
|
355 | FAS, ALPS1A, APO-1, APT1, CD95, FAS1, FASTM, TNFRSF6 | Fas cell surface death receptor |
C00000919
|
3169 | FOXA1, HNF3A, TCF3A | forkhead box A1 |
C00000919
|
2627 | GATA6 | GATA binding protein 6 |
C00000919
|
2633 | GBP1 | guanylate binding protein 1, interferon-inducible |
C00000919
|
81025 | GJA9, CX58, CX59, GJA10 | gap junction protein, alpha 9, 59kDa |
C00000919
|
373156 | GSTK1, GST, GST_13-13, GST13, GST13-13, GSTK1-1, hGSTK1 | glutathione S-transferase kappa 1 (EC:2.5.1.18) |
C00000919
|
2946 | GSTM2, GST4, GSTM, GSTM2-2, GTHMUS | glutathione S-transferase mu 2 (muscle) (EC:2.5.1.18) |
C00000919
|
2948 | GSTM4, GSTM4-4, GTM4 | glutathione S-transferase mu 4 (EC:2.5.1.18) |
C00000919
|
2949 | GSTM5, GSTM5-5, GTM5 | glutathione S-transferase mu 5 (EC:2.5.1.18) |
C00000919
|
2954 | GSTZ1, GSTZ1-1, MAAI, MAI | glutathione S-transferase zeta 1 (EC:2.5.1.18 5.2.1.2) |
C00000919
|
3204 | HOXA7, ANTP, HOX1, HOX1.1, HOX1A | homeobox A7 |
C00000919
|
3216 | HOXB6, HOX2, HOX2B, HU-2, Hox-2.2 | homeobox B6 |
C00000919
|
3226 | HOXC10, HOX3I | homeobox C10 |
C00000919
|
3448 | IFNA14, IFN-alphaH, LEIF2H | interferon, alpha 14 |
C00000919
|
3449 | IFNA16, IFN-alphaO | interferon, alpha 16 |
C00000919
|
3451 | IFNA17, IFN-alphaI, IFNA, INFA, LEIF2C1 | interferon, alpha 17 |
C00000919
|
3442 | IFNA5, IFN-alpha-5, IFN-alphaG, INA5, INFA5, leIF_G | interferon, alpha 5 |
C00000919
|
3553 | IL1B, IL-1, IL1-BETA, IL1F2 | interleukin 1, beta |
C00000919
|
3394 | IRF8, H-ICSBP, ICSBP, ICSBP1, IRF-8 | interferon regulatory factor 8 |
C00000919
|
50805 | IRX4, IRXA3 | iroquois homeobox 4 |
C00000919
|
3688 | ITGB1, CD29, FNRB, GPIIA, MDF2, MSK12, VLA-BETA, VLAB | integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) |
C00000919
|
3691 | ITGB4, CD104 | integrin, beta 4 |
C00000919
|
3875 | KRT18, CYK18, K18 | keratin 18 |
C00000919
|
3880 | KRT19, CK19, K19, K1CS | keratin 19 |
C00000919
|
3849 | KRT2, CK-2e, K2e, KRT2A, KRT2E, KRTE | keratin 2 |
C00000919
|
3855 | KRT7, CK7, K2C7, K7, SCL | keratin 7 |
C00000919
|
3856 | KRT8, CARD2, CK-8, CK8, CYK8, K2C8, K8, KO | keratin 8 |
C00000919
|
8022 | LHX3, CPHD3, LIM3, M2-LHX3 | LIM homeobox 3 |
C00000919
|
2353 | FOS, AP-1, C-FOS, p55 | FBJ murine osteosarcoma viral oncogene homolog |
C00000911
|
4170 | MCL1, BCL2L3, EAT, MCL1-ES, MCL1L, MCL1S, Mcl-1, TM, bcl2-L-3, mcl1/EAT | myeloid cell leukemia sequence 1 (BCL2-related) |
C00000919
|
4212 | MEIS2, HsT18361, MRG1 | Meis homeobox 2 |
C00000919
|
4222 | MEOX1, KFS2, MOX1 | mesenchyme homeobox 1 |
C00000919
|
3110 | MNX1, HB9, HLXB9, HOXHB9, SCRA1 | motor neuron and pancreas homeobox 1 |
C00000919
|
4439 | MSH5, G7, MUTSH5, NG23 | mutS homolog 5 |
C00000919
|
4586 | MUC5AC, MUC5, TBM, leB | mucin 5AC, oligomeric mucus/gel-forming |
C00000919
|
8856 | NR1I2, BXR, ONR1, PAR, PAR1, PAR2, PARq, PRR, PXR, SAR, SXR | nuclear receptor subfamily 1, group I, member 2 |
C00000919
|
4973 | OLR1, CLEC8A, LOX1, LOXIN, SCARE1, SLOX1 | oxidized low density lipoprotein (lectin-like) receptor 1 |
C00000919
|
5098 | PCDHGC3, PC43, PCDH-GAMMA-C3, PCDH2 | protocadherin gamma subfamily C, 3 |
C00000919
|
5359 | PLSCR1, MMTRA1B | phospholipid scramblase 1 |
C00000919
|
57048 | PLSCR3 | phospholipid scramblase 3 |
C00000919
|
57088 | PLSCR4, TRA1 | phospholipid scramblase 4 |
C00000919
|
10635 | RAD51AP1, PIR51 | RAD51 associated protein 1 |
C00000919
|
5892 | RAD51D, BROVCA4, R51H3, RAD51L3, TRAD | RAD51 paralog D |
C00000919
|
5914 | RARA, NR1B1, RAR | retinoic acid receptor, alpha |
C00000919
|
5915 | RARB, HAP, NR1B2, RRB2 | retinoic acid receptor, beta |
C00000919
|
5918 | RARRES1, LXNL, TIG1 | retinoic acid receptor responder (tazarotene induced) 1 |
C00000919
|
5950 | RBP4, RDCCAS | retinol binding protein 4, plasma |
C00000919
|
6256 | RXRA, NR2B1 | retinoid X receptor, alpha |
C00000919
|
949 | SCARB1, CD36L1, CLA-1, CLA1, HDLQTL6, SR-BI, SRB1 | scavenger receptor class B, member 1 |
C00000919
|
4990 | SIX6, MCOPCT2, OPTX2, Six9 | SIX homeobox 6 |
C00000919
|
6647 | SOD1, ALS, ALS1, IPOA, SOD, hSod1, homodimer | superoxide dismutase 1, soluble (EC:1.15.1.1) |
C00000919
|
9517 | SPTLC2, HSN1C, LCB2, LCB2A, NSAN1C, SPT2, hLCB2a | serine palmitoyltransferase, long chain base subunit 2 (EC:2.3.1.50) |
C00000919
|
6720 | SREBF1, SREBP-1c, SREBP1, bHLHd1 | sterol regulatory element binding transcription factor 1 |
C00000919
|
7052 | TGM2, G-ALPHA-h, GNAH, TG2, TGC | transglutaminase 2 (EC:2.3.2.13) |
C00000919
|
7047 | TGM4, TGP, hTGP | transglutaminase 4 (EC:2.3.2.13) |
C00000919
|
3604 | TNFRSF9, 4-1BB, CD137, CDw137, ILA | tumor necrosis factor receptor superfamily, member 9 |
C00000919
|
8743 | TNFSF10, APO2L, Apo-2L, CD253, TL2, TRAIL | tumor necrosis factor (ligand) superfamily, member 10 |
C00000919
|
10190 | TXNDC9, APACD, PHLP3 | thioredoxin domain containing 9 |
C00000919
|
7517 | XRCC3, CMM6 | X-ray repair complementing defective repair in Chinese hamster cells 3 |
C00000919
|
OMIM | preferred title | UniProt |
---|---|---|
#300438 | 17-beta-hydroxysteroid dehydrogenase x deficiency |
Q99714
|
#202300 | Adrenocortical carcinoma, hereditary; adcc |
P04637
|
#218030 | Apparent mineralocorticoid excess; ame |
P80365
|
#600807 | Asthma, susceptibility to |
Q13093
|
#614740 | Basal cell carcinoma, susceptibility to, 7; bcc7 |
P04637
|
#601816 | Bilirubin, serum level of, quantitative trait locus 1; biliqtl1 |
P22309
|
#115200 | Cardiomyopathy, dilated, 1a; cmd1a |
P02545
|
#212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism |
P02545
|
#605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 |
P02545
|
#114500 | Colorectal cancer; crc |
P84022
|
#604931 | Cortisone reductase deficiency 1; cortrd1 |
P28845
|
#218800 | Crigler-najjar syndrome, type i |
P22309
|
#606785 | Crigler-najjar syndrome, type ii |
P22309
|
#119900 | Digital clubbing, isolated congenital |
P15428
|
#181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 |
P02545
|
#133239 | Esophageal cancer |
P04637
|
#615363 | Estrogen resistance; estrr |
P03372
|
#612219 | Ewing sarcoma; es |
P11308
|
#600274 | Frontotemporal dementia; ftd |
P10636
|
#143500 | Gilbert syndrome |
P22309
|
#232600 | Glycogen storage disease v |
P11217
|
#610140 | Heart-hand syndrome, slovenian type |
P02545
|
#614519 | Hemorrhage, intracerebral, susceptibility to; ich |
P12821
|
#114550 | Hepatocellular carcinoma |
P08581
|
#143100 | Huntington disease; hd |
P42858
|
#176670 | Hutchinson-gilford progeria syndrome; hgps |
P02545
|
#237900 | Hyperbilirubinemia, transient familial neonatal; hblrtfn |
P22309
|
#143860 | Hyperchlorhidrosis, isolated |
O43570
|
#603373 | Hyperthyroidism, familial gestational |
P16473
|
#609152 | Hyperthyroidism, nonautoimmune |
P16473
|
#259100 | Hypertrophic osteoarthropathy, primary, autosomal recessive, 1; phoar1 |
P15428
|
#275200 | Hypothyroidism, congenital, nongoitrous, 1; chng1 |
P16473
|
#147050 | Ige responsiveness, atopic; iger |
Q13093
|
#614328 | Inflammatory skin and bowel disease, neonatal; nisbd |
P78536
|
#151623 | Li-fraumeni syndrome 1; lfs1 |
P04637
|
#151660 | Lipodystrophy, familial partial, type 2; fpld2 |
P02545
|
#613795 | Loeys-dietz syndrome, type 3; lds3 |
P84022
|
#211980 | Lung cancer |
P04637
|
#248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada |
P02545
|
#300705 | Mental retardation, x-linked 17; mrx17 |
Q99714
|
#300220 | Mental retardation, x-linked, syndromic 10; mrxs10 |
Q99714
|
#612624 | Microvascular complications of diabetes, susceptibility to, 3; mvcd3 |
P12821
|
#613205 | Muscular dystrophy, congenital, lmna-related |
P02545
|
#159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b |
P02545
|
#607948 | Mycobacterium tuberculosis, susceptibility to |
P11473
|
#259730 | Osteopetrosis, autosomal recessive 3; optb3 |
P00918
|
#260500 | Papilloma of choroid plexus; cpp |
P04637
|
#260540 | Parkinson-dementia syndrome |
P10636
|
#172700 | Pick disease of brain |
P10636
|
#614278 | Platelet-activating factor acetylhydrolase deficiency; pafad |
Q13093
|
#614390 | Pregnancy loss, recurrent, susceptibility to, 2; rprgl2 |
P00734
|
#613679 | Prothrombin deficiency, congenital |
P00734
|
#605074 | Renal cell carcinoma, papillary, 1; rccp1 |
P08581
|
#267430 | Renal tubular dysgenesis; rtd |
P12821
|
#607276 | Resting heart rate, variation in |
P08588
|
#275210 | Restrictive dermopathy, lethal |
P02545
|
#600852 | Retinitis pigmentosa 17; rp17 |
P22748
|
#253300 | Spinal muscular atrophy, type i; sma1 |
Q16637
|
#253550 | Spinal muscular atrophy, type ii; sma2 |
Q16637
|
#253400 | Spinal muscular atrophy, type iii; sma3 |
Q16637
|
#271150 | Spinal muscular atrophy, type iv; sma4 |
Q16637
|
#605361 | Spinocerebellar ataxia 14; sca14 |
P05129
|
#183090 | Spinocerebellar ataxia 2; sca2 |
Q99700
|
#607250 | Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy; scan1 |
Q9NUW8
|
#275355 | Squamous cell carcinoma, head and neck; hnscc |
P04637
|
#601367 | Stroke, ischemic |
P00734
P12821 P16109 P24723 |
#601104 | Supranuclear palsy, progressive, 1; psnp1 |
P10636
|
#188050 | Thrombophilia due to thrombin defect; thph1 |
P00734
|
#277440 | Vitamin d-dependent rickets, type 2a; vddr2a |
P11473
|
#278750 | Xeroderma pigmentosum, variant type; xpv |
Q9Y253
|
KEGG | name | UniProt |
---|---|---|
H01302 | Hyperchlorhidrosis isolated (HCHLH) |
O43570
(related)
|
H00021 | Renal cell carcinoma |
O43570
(marker)
P04637 (marker) P08581 (related) Q16790 (marker) |
H00223 | Inherited thrombophilia |
P00734
(related)
|
H01254 | Congenital prothrombin deficiency |
P00734
(related)
|
H00241 | Combined proximal and distal renal tubular acidosis (RTA type 3) |
P00918
(related)
|
H00436 | Osteopetrosis |
P00918
(related)
|
H00264 | Charcot-Marie-Tooth disease (CMT) |
P02545
(related)
|
H00294 | Dilated cardiomyopathy (DCM) |
P02545
(related)
|
H00420 | Familial partial lipodystrophy (FPL) |
P02545
(related)
|
H00563 | Emery-Dreifuss muscular dystrophy |
P02545
(related)
|
H00590 | Congenital muscular dystrophies (CMD/MDC) |
P02545
(related)
|
H00593 | Limb-girdle muscular dystrophy (LGMD) |
P02545
(related)
|
H00601 | Hutchinson-Gilford progeria syndrome |
P02545
(related)
|
H00663 | Restrictive dermopathy |
P02545
(related)
|
H00665 | Mandibuloacral dysplasia |
P02545
(related)
|
H01216 | Left ventricular noncompaction (LVNC) |
P02545
(related)
|
H00026 | Endometrial Cancer |
P03372
(marker)
P04637 (related) |
H00599 | 46,XX disorders of sex development (Disorders related to androgen excess) |
P04150
(related)
|
H00004 | Chronic myeloid leukemia (CML) |
P04637
(related)
|
H00005 | Chronic lymphocytic leukemia (CLL) |
P04637
(related)
|
H00006 | Hairy-cell leukemia |
P04637
(related)
|
H00008 | Burkitt lymphoma |
P04637
(related)
|
H00009 | Adult T-cell leukemia |
P04637
(related)
|
H00010 | Multiple myeloma |
P04637
(related)
|
H00013 | Small cell lung cancer |
P04637
(related)
|
H00014 | Non-small cell lung cancer |
P04637
(related)
|
H00015 | Malignant pleural mesothelioma |
P04637
(related)
|
H00016 | Oral cancer |
P04637
(related)
P04637 (marker) |
H00017 | Esophageal cancer |
P04637
(related)
P04637 (marker) P35354 (related) |
H00018 | Gastric cancer |
P04637
(related)
P08581 (related) |
H00019 | Pancreatic cancer |
P04637
(related)
P04637 (marker) |
H00020 | Colorectal cancer |
P04637
(related)
P04637 (marker) |
H00022 | Bladder cancer |
P04637
(related)
|
H00025 | Penile cancer |
P04637
(related)
P04637 (marker) P35354 (related) |
H00027 | Ovarian cancer |
P04637
(related)
|
H00028 | Choriocarcinoma |
P04637
(related)
|
H00029 | Vulvar cancer |
P04637
(related)
|
H00031 | Breast cancer |
P04637
(related)
|
H00032 | Thyroid cancer |
P04637
(related)
|
H00033 | Adrenal carcinoma |
P04637
(related)
|
H00036 | Osteosarcoma |
P04637
(related)
P08684 (marker) |
H00038 | Malignant melanoma |
P04637
(related)
|
H00039 | Basal cell carcinoma |
P04637
(related)
|
H00040 | Squamous cell carcinoma |
P04637
(related)
|
H00041 | Kaposi's sarcoma |
P04637
(related)
|
H00042 | Glioma |
P04637
(related)
P04637 (marker) |
H00044 | Cancer of the anal canal |
P04637
(related)
|
H00046 | Cholangiocarcinoma |
P04637
(related)
P08581 (related) P35354 (related) |
H00047 | Gallbladder cancer |
P04637
(related)
|
H00048 | Hepatocellular carcinoma |
P04637
(related)
|
H00055 | Laryngeal cancer |
P04637
(related)
P04637 (marker) |
H00881 | Li-Fraumeni syndrome |
P04637
(related)
|
H01007 | Choroid plexus papilloma |
P04637
(related)
|
H00063 | Spinocerebellar ataxia (SCA) |
P05129
(related)
Q99700 (related) Q9NUW8 (related) |
H00079 | Asthma |
P07550
(related)
|
H00058 | Amyotrophic lateral sclerosis (ALS) |
P10636
(related)
|
H00077 | Progressive supranuclear palsy (PSP) |
P10636
(related)
|
H00078 | Frontotemporal lobar degeneration (FTLD) |
P10636
(related)
|
H00069 | Glycogen storage diseases (GSD) |
P11217
(related)
|
H00024 | Prostate cancer |
P11308
(related)
|
H00035 | Ewing's sarcoma |
P11308
(related)
|
H00342 | Tuberculosis |
P11473
(related)
|
H00784 | Localized autosomal recessive hypotrichosis |
P11473
(related)
|
H01143 | Vitamin D-dependent rickets |
P11473
(related)
|
H00083 | Allograft rejection |
P12821
(related)
|
H00575 | Renal tubular dysgenesis |
P12821
(related)
|
H00457 | Primary hypertrophic osteoarthropathy (PHO) |
P15428
(related)
|
H01246 | Isolated congenital nail clubbing (ICNC) |
P15428
(related)
|
H00250 | Congenital nongoitrous hypothyroidism (CHNG) |
P16473
(related)
|
H01269 | Congenital hyperthyroidism |
P16473
(related)
|
H00408 | Type I diabetes mellitus |
P17706
(related)
Q04759 (related) |
H00208 | Hyperbilirubinemia |
P22309
(related)
|
H00527 | Retinitis pigmentosa (RP) |
P22748
(related)
|
H01111 | Cortisone reductase deficiency (CRD) |
P28845
(related)
|
H00059 | Huntington's disease (HD) |
P42858
(related)
|
H00259 | Apparent mineralocorticoid excess syndrome |
P80365
(related)
|
H00455 | Spinal muscular atrophy (SMA) |
Q16637
(related)
|
H00480 | Non-syndromic X-linked mental retardation |
Q99714
(related)
|
H00658 | Syndromic X-linked mental retardation |
Q99714
(related)
|
H00925 | 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency |
Q99714
(related)
|
H00403 | Disorders of nucleotide excision repair |
Q9Y253
(related)
|
MESH or OMIM | name |
KNApSAcK
metabolite |
---|---|---|
D056486 | Drug-Induced Liver Injury |
C00000911
C00000919 |
D009369 | Neoplasms |
C00000911
C00000919 |
D006943 | Hyperglycemia |
C00000911
C00002647 |
D009069 | Movement Disorders |
C00002647
|
D013118 | Spinal Cord Diseases |
C00019308
|
D006965 | Hyperplasia |
C00000911
|
D007248 | Infertility, Male |
C00000911
|
D007249 | Inflammation |
C00000911
|
D007674 | Kidney Diseases |
C00000911
|
D003072 | Cognition Disorders |
C00019308
|
D020258 | Neurotoxicity Syndromes |
C00000911
|
D011471 | Prostatic Neoplasms |
C00000911
|
D012878 | Skin Neoplasms |
C00000911
|
D013733 | Testicular Diseases |
C00000911
|
D014178 | Translocation, Genetic |
C00000911
|
D015431 | Weight Loss |
C00000911
|
D003921 | Diabetes Mellitus, Experimental |
C00002647
|
D050171 | Dyslipidemias |
C00002647
|
D005234 | Fatty Liver |
C00002647
|
D018149 | Glucose Intolerance |
C00002647
|
D006937 | Hypercholesterolemia |
C00002647
|
D006949 | Hyperlipidemias |
C00002647
|
D015228 | Hypertriglyceridemia |
C00002647
|
D015464 | Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
C00002647
|
D008546 | Melanoma, Experimental |
C00002647
|
D002493 | Central Nervous System Diseases |
C00019308
|
D009203 | Myocardial Infarction |
C00002647
|
D009361 | Neoplasm Invasiveness |
C00002647
|
D009362 | Neoplasm Metastasis |
C00002647
|
D012516 | Osteosarcoma |
C00002647
|
D010182 | Pancreatic Diseases |
C00002647
|
D007939 | Leukemia L1210 |
C00003776
|
D014605 | Uveitis |
C00003776
|
D000435 | Alcoholic Intoxication |
C00000919
|
D001145 | Arrhythmias, Cardiac |
C00000919
|
D053627 | Asthenozoospermia |
C00000919
|
D002545 | Brain Ischemia |
C00000919
|
D006528 | Carcinoma, Hepatocellular |
C00000919
|
D002318 | Cardiovascular Diseases |
C00000919
|
D003930 | Diabetic Retinopathy |
C00000919
|
D006526 | Hepatitis C |
C00000919
|
D015658 | HIV Infections |
C00000919
|
D006986 | Hypervitaminosis A |
C00000919
|
D008107 | Liver Diseases |
C00000919
|
D008113 | Liver Neoplasms |
C00000919
|
D008114 | Liver Neoplasms, Experimental |
C00000919
|
D008175 | Lung Neoplasms |
C00000919
|
D009845 | Oligospermia |
C00000919
|
D013272 | Stomach Diseases |
C00000919
|
D013276 | Stomach Ulcer |
C00000919
|